In addition, t-PA treatment carries life-threatening risks, mainly for development of symptomatic intracerebral hemorrhage (sICH), which has been associated with t-PA-mediated disruption of the blood brain-barrier (BBB) (4). Here, PLAT is linked to intracerebral hemorrhage.